Aims:
The Primary Aim of this study is to develop a value set for the EQ-5D-5L health states based on the preferences of the Qatari general population.
Secondary aims are to:
- Examine the construct validity of the EQ-5D-5L instrument in Qatar general adult population.
- Develop population norms for the EQ-5D-5L.
- Identify determinants of preferences in the Qatari population.
- Explore the impact of culture and religion on completing preference elicitation exercises; and
- Compare value sets derived from cTTO-based, hybrid, and DCE with duration (DCEd) methodologies, in order to assess the consistency and agreement among these valuation approaches.
Methods:
This will be a cross-sectional population-based study involving interviewer-administered in person or online interviews following the EuroQol EQ-5D-5L valuation protocol and using the EuroQol Valuation Technology (EQ-VT).
A sample of 1150 adults will be recruited from the Qatari general population using a two-stage quota sampling.
Interviews will be conducted by trained research assistants who will undergo a 3-day training and will take place at a private and convenient settings depending on the participant’s preferences.
EuroQol quality control processes will be followed to ensure high quality data.
Principal Investigators
EQ-5D-5L Valuation Study in Qatar
Co-investigators:
Dr. Marcel Jonker, PhD, EuroQol Research Foundation
Dr. Dina Abushanab, PhD, ISPOR – The Professional Society of Health Economics and Outcomes Research.
Dr. Daoud Al-Badriyeh, PhD, Professor of Pharmacoeconomics and Outcomes Research, College of Pharmacy, Qatar university
Dr. Bram Roudjik, PhD, EuroQol Research Foundation
Dr. Christiane Maskineh, PhD, CEO CCHO.
Dr. Mirna Matni, PharmD, MSC Tox, Director P&R & Health Policy Insights, CCHO.
Study Coordinator
- Youmna Bassil (CCHO)
- Caline Saade (CCHO)
Duration of Project ( months)
18 months
